KRTL Holding Group Inc. (OTC: KRTL) has completed a strategic merger between its subsidiary, KRTL Biotech Inc., and Bolivian pharmaceutical company Industria Químico Farmacéutica Sigma Corp. S.R.L. (SIGMA). The agreement, finalized on Sept. 2, 2025, gives KRTL Biotech a 99% controlling interest in SIGMA, in exchange for 49% ownership in KRTL Biotech by SIGMA’s founding…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here